Chemical Compound

Toceranib

CAS Registry Number 356068-94-5
Toceranib chemical structure
Primary Record

Toceranib

In stock
9,102 g
Purity
98.3 %
CAS
356068-94-5

Compound Identifiers & Properties

CAS
356068-94-5
PubChem CID
5329106
SMILES
CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O
Canonical SMILES
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1

Names & Synonyms

  • Toceranib
  • Palladia
  • 356068-94-5
  • toceranibum
  • Palladiar
  • Toceranib free base
  • Toceranib [USAN]
  • Toceranib (USAN)
  • Toceranib [USAN:INN]
  • RefChem:57436
  • TOCERANIB [INN]
  • TOCERANIB [MI]
  • SU11248 analog 12f
  • UNII-59L7Y0530C
  • AC1NS62V
  • PHA-291639
  • MFCD16038046
  • C22H25FN4O2
  • CHEMBL13608
  • SU 11654
  • DTXSID50189076
  • BDBM4818
  • orb1708344
  • SCHEMBL2116670
  • 59L7Y0530C
  • SCHEMBL29354429
  • GTPL11619
  • DTXCID80111567
  • QCR-132
  • SRSGVKWWVXWSJT-ATVHPVEESA-N
  • SU-11654
  • AOB87353
  • ZINC3989258
  • 4124AH
  • PHA291639
  • AKOS024457864
  • AN-3597
  • CID5329106
  • CS-0241
  • EBC-312078
  • FT44529
  • PHA 291639
  • SU11654
  • TOCERANIB (EMA EPAR VETERINARY)
  • TOCERANIB [EMA EPAR VETERINARY]
  • compound 12f [PMID: 12646019]
  • NCGC00378902-03
  • NCGC00378902-05
  • AC-26968
  • AS-31877
  • HY-10330
  • SC-87730
  • ToceranibDiscontinued Pfizer Patent issues
  • BCP0726000021
  • AB0072276
  • DB-225126
  • Toceranib(SU 11654; PHA 291639)
  • 4720B
  • A3879
  • FT-0675258
  • Toceranib(SU 11654; PHA 291639)?
  • (Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide
  • J3.311.001D
  • A11581
  • D08503
  • W-5604
  • (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
  • EN300-7399740
  • A874574
  • 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
  • BRD-K62040061-001-01-0
  • BRD-K62040061-011-01-9
  • B0084-455463
  • 5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (Z)-5-((5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-N-(2-PYRROLIDIN-1-YLETHYL)-1H-PYRROLE-3-CARBOXAMIDE
  • 1H-PYRROLE-3-CARBOXAMIDE, 5-((Z)-(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-N-(2-(1-PYRROLIDINYL)ETHYL)-
  • 5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
  • 5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
  • 5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
  • 5-((Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-N-(2-(PYRROLIDIN-1-YL)ETHYL)-1H-PYRROLE-3-CARBOXAMIDE
  • 5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide
  • 5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid (2-(Pyrrolidin-1-yl)ethyl)amide
  • 5-[(Z)-(5-fluoranyl-2-oxidanylidene-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
  • 5-[5-fluoro-2-oxo-1, 2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide
  • 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3 Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide
  • 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide
  • 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide
  • N-[2-(Pyrrolidine-1-yl)ethyl]-5-[(Z)-(2,3-dihydro-2-oxo-5-fluoro-1H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide